Variant report

Variant	nsv984212
Chromosome Location	chr15:92562075-92570410
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr15:92567168..92568935-chr15:92570606..92572185,2	K562	blood:
2	chr15:92562839..92565166-chr15:92567346..92570436,4	MCF-7	breast:
3	chr15:92562839..92565166-chr15:92567346..92570436,4	MCF-7	breast:

Extended variants
information (count: 365 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:365 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs185145066	chr15:92562083-92562084	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs539657555	chr15:92562101-92562102	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs190393579	chr15:92562106-92562107	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs576560303	chr15:92562116-92562117	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs140404580	chr15:92562133-92562134	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs149946842	chr15:92562140-92562141	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs574098408	chr15:92562153-92562154	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs539814921	chr15:92562170-92562171	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs112773674	chr15:92562176-92562177	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs28689627	chr15:92562184-92562185	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs576906563	chr15:92562186-92562187	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs545557516	chr15:92562191-92562192	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs562749492	chr15:92562196-92562197	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs115656626	chr15:92562241-92562242	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs548512368	chr15:92562269-92562270	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs7166185	chr15:92562292-92562293	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs527706925	chr15:92562295-92562296	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs201820072	chr15:92562310-92562311	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs34673014	chr15:92562311-92562312	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs184808233	chr15:92562312-92562313	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs530943860	chr15:92562314-92562315	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs76893965	chr15:92562365-92562366	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs16946261	chr15:92562369-92562370	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
24	rs59734462	chr15:92562384-92562385	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs16946262	chr15:92562393-92562394	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs180729309	chr15:92562407-92562408	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs145030471	chr15:92562467-92562468	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs534971833	chr15:92562489-92562490	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs553378921	chr15:92562508-92562509	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs142167988	chr15:92562511-92562512	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs145897366	chr15:92562555-92562556	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs566943062	chr15:92562571-92562572	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs138714715	chr15:92562575-92562576	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs58901888	chr15:92562592-92562593	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs78546760	chr15:92562616-92562617	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs7171137	chr15:92562627-92562628	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
37	rs542265171	chr15:92562640-92562641	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs541332452	chr15:92562683-92562684	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs564548269	chr15:92562698-92562699	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs533136805	chr15:92562699-92562700	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs12905261	chr15:92562720-92562721	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs570024973	chr15:92562748-92562749	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs376110333	chr15:92562762-92562763	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs114632800	chr15:92562787-92562788	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs115293616	chr15:92562828-92562829	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs528062882	chr15:92562989-92562990	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs12905735	chr15:92562990-92562991	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs16946268	chr15:92562993-92562994	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs548279889	chr15:92563000-92563001	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs570435694	chr15:92563027-92563028	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Wilms tumour	21544195	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Melanoma	18172304	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Cancer	16751803	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	16864856	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Sudden cardiac death	19188705	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Epilepsy	19486360	CNVD
Acute myeloid leukemia	17237825	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Ovarian cancer	21720365	CNVD
Developmental delay	21147756	CNVD
Hepatocellular carcinoma	16750200	CNVD
Central neurocytomas	17123091	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Myelofibrosis	22110671	CNVD
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	21339820	CNVD

Chromatin state (count:185 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:92550800-92562600	Weak transcription	Sigmoid Colon	Sigmoid Colon
2	chr15:92554200-92566200	Enhancers	Right Atrium	heart
3	chr15:92555400-92564200	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
4	chr15:92555600-92563200	Enhancers	Brain Cingulate Gyrus	brain
5	chr15:92555600-92563200	Enhancers	Brain Hippocampus Middle	brain
6	chr15:92555600-92564000	Weak transcription	Primary T killer memory cells from peripheral blood	blood
7	chr15:92555600-92565600	Weak transcription	Gastric	stomach
8	chr15:92555600-92570600	Weak transcription	Monocytes-CD14+_RO01746	blood
9	chr15:92555600-92576200	Enhancers	Breast Myoepithelial Primary Cells	Breast
10	chr15:92555800-92564200	Weak transcription	Primary T helper naive cells from peripheral blood	blood
11	chr15:92556000-92564200	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
12	chr15:92556800-92565000	Weak transcription	Skeletal Muscle Female	skeletal muscle
13	chr15:92556800-92565200	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
14	chr15:92557000-92562800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr15:92557800-92567000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
16	chr15:92558000-92562600	Enhancers	Spleen	Spleen
17	chr15:92558000-92571200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
18	chr15:92558600-92568600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
19	chr15:92559000-92562600	Weak transcription	Aorta	Aorta
20	chr15:92559200-92562200	Weak transcription	Brain Substantia Nigra	brain
21	chr15:92559200-92564000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
22	chr15:92559400-92564400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr15:92560600-92562200	Enhancers	Primary T cells fromperipheralblood	blood
24	chr15:92560800-92563400	Enhancers	Left Ventricle	heart
25	chr15:92561000-92562600	Enhancers	Lung	lung
26	chr15:92561000-92562800	Enhancers	Esophagus	oesophagus
27	chr15:92561000-92562800	Enhancers	Ovary	ovary
28	chr15:92561000-92563400	Enhancers	Right Ventricle	heart
29	chr15:92561400-92565200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
30	chr15:92561600-92562600	Enhancers	Primary T helper cells PMA-I stimulated	--
31	chr15:92561600-92562800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr15:92561600-92563000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
33	chr15:92561800-92562200	Enhancers	Psoas Muscle	Psoas
34	chr15:92561800-92562400	Enhancers	Brain Anterior Caudate	brain
35	chr15:92561800-92562800	Enhancers	NHEK	skin
36	chr15:92561800-92564400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
37	chr15:92561800-92564600	Enhancers	Pancreas	Pancrea
38	chr15:92561800-92565000	Weak transcription	Brain Angular Gyrus	brain
39	chr15:92562000-92562400	Enhancers	Fetal Heart	heart
40	chr15:92562000-92567800	Weak transcription	Brain Inferior Temporal Lobe	brain
41	chr15:92562200-92563800	Enhancers	Brain Substantia Nigra	brain
42	chr15:92562200-92565000	Weak transcription	Primary T cells fromperipheralblood	blood
43	chr15:92562400-92562600	Enhancers	Skeletal Muscle Male	skeletal muscle
44	chr15:92562400-92562800	Flanking Active TSS	Fetal Heart	heart
45	chr15:92562400-92564800	Weak transcription	Brain Anterior Caudate	brain
46	chr15:92562600-92563000	Weak transcription	Lung	lung
47	chr15:92562600-92563200	Enhancers	Sigmoid Colon	Sigmoid Colon
48	chr15:92562600-92563400	Enhancers	Aorta	Aorta
49	chr15:92562600-92563800	Weak transcription	Spleen	Spleen
50	chr15:92562600-92564400	Weak transcription	Primary T helper cells PMA-I stimulated	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links